gov.uk: Medicines and Healthcare products Regulatory AgencyUnited Kingdom13 October 2026
MHRA authorises Onswik (insulin efsitora alfa) for adults with type 2 diabetes
This is an official announcement record
Firsthand records what gov.uk: Medicines and Healthcare products Regulatory Agency announced and links to the original. The wording below is theirs, not ours.
The new treatment option is administered once weekly, potentially reducing the number of injections from up to 365 a year to 52 for some adults with type 2 diabetes.
Read the official announcement
Opens www.gov.uk
More from gov.uk: Medicines and Healthcare products Regulatory Agency
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.